| scholarly article | Q13442814 |
| P50 | author | Luis E. Cuevas | Q37842536 |
| Lovett Lawson | Q50595282 | ||
| Olanrewaju Oladimeji | Q85396568 | ||
| P2093 | author name string | Russell Dacombe | |
| Nnamdi Emenyonu | |||
| Saddiq Tsimiri Abdurrahman | |||
| Muhammad Muhammad | |||
| Olusegun Joshua Obasanya | |||
| P2860 | cites work | Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa | Q36424212 |
| TB diagnostic tests: how do we figure out their costs? | Q37579924 | ||
| Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa | Q44058941 | ||
| Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis | Q28477855 | ||
| Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa | Q34878574 | ||
| P921 | main subject | Nigeria | Q1033 |
| tuberculosis | Q12204 | ||
| P304 | page(s) | 277 | |
| P577 | publication date | 2014-08-05 | |
| P1433 | published in | The Pan African medical journal | Q27722840 |
| P1476 | title | The hidden costs of installing Xpert machines in a tuberculosis high-burden country: experiences from Nigeria | |
| P478 | volume | 18 |
| Q90950647 | A modular paper-and-plastic device for tuberculosis nucleic acid amplification testing in limited-resource settings |
| Q36159840 | Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda |
| Q36335270 | Diagnostics for Developing Countries |
| Q33742861 | Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study |
| Q92778926 | Governance of tuberculosis control programme in Nigeria |
| Q38853460 | Higher cost of implementing Xpert(®) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness. |
| Q91810063 | PrimeStore MTM and OMNIgene Sputum for the Preservation of Sputum for Xpert MTB/RIF Testing in Nigeria |
| Q37446922 | Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe |
| Q41677504 | Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria. |
| Q60922641 | Xpert MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis |
Search more.